Malignant gastrointestinal stromal tumours treated with imatinib in France: results in unselected patients

被引：0
|
作者：
Bouche, O. [1 ]
Cioffi, A. [2 ]
Rios, M. [3 ]
Blesius, A. [4 ]
Chaigneau, L. [5 ]
Ray-Coquard, I. [6 ]
Blay, J. Y.
Le Cesne, A. [2 ]
Bisot-Locard, S.
Deschaseaux, C. [7 ]
机构：
[1] CHU Reims, Serv Hepatogastroenterol & Cancerol Digest, Reims, France
[2] Inst Gustave Roussy, Villejuif, France
[3] Ctr Alexis Vautrin, Vandoeuvre Les Nancy, France
[4] Hop Enfants La Timone, Marseille, France
[5] Hop Jean Minjoz, F-25030 Besancon, France
[6] Ctr Leon Berard, Dept Oncol Med Adulte, F-69373 Lyon, France
[7] Novartis Pharmaceut, Market Access, Rueil Malmaison, France
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 02期
关键词：
D O I：
10.1016/S1359-6349(09)72003-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：594 / 594
页数：1
相关论文
共 50 条
  • [31] Is there a role for post-imatinib surgery in advanced gastrointestinal stromal tumours?
    Kuhlmann, K. F. D.
    Kerst, J. M.
    Cats, A.
    van Coevorden, F.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2009, 21 (03) : A3 - A3
  • [32] Management of gastrointestinal stromal tumours in the Imatinib era: a surgeon's perspective
    Ravindra S Date
    Nicholas A Stylianides
    Kishore G Pursnani
    Jeremy B Ward
    Muntzer M Mughal
    World Journal of Surgical Oncology, 6
  • [33] Gastrointestinal stromal tumours and their response to treatment with the tyrosine kinase inhibitor imatinib
    Mechtersheimer, G
    Egerer, G
    Hensel, M
    Rieker, RJ
    Libicher, M
    Lehnert, T
    Penzel, R
    VIRCHOWS ARCHIV, 2004, 444 (02) : 108 - 118
  • [34] Optimal Duration of Imatinib Mesylate Therapy in Metastatic Gastrointestinal Stromal Tumours
    Gauden, Ruth
    Gauden, Stan
    CASE REPORTS IN ONCOLOGY, 2011, 4 (01): : 204 - 210
  • [35] ImatinibDevelopment of imatinib resistance mutation in gastrointestinal stromal tumours: case report
    Reactions Weekly, 2016, 1618 (1) : 93 - 93
  • [36] Gastrointestinal stromal tumours in the elderly patients
    Tham, C. K.
    Li, H. H.
    Tan, M. H.
    Tien, M.
    Poon, D.
    Foo, K. F.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2007, 64 : S48 - S48
  • [37] Prediction of free imatinib concentrations based on total plasma concentrations in patients with gastrointestinal stromal tumours
    Haouala, Amina
    Widmer, Nicolas
    Guidi, Monia
    Montemurro, Michael
    Leyvraz, Serge
    Buclin, Thierry
    Eap, Chin B.
    Decosterd, Laurent A.
    Csajka, Chantal
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 75 (04) : 1007 - 1018
  • [38] ImatinibDevelopment of imatinib resistance mutation in gastrointestinal stromal tumours: case report
    Reactions Weekly, 2016, 1590 (1) : 112 - 112
  • [39] Measuring Tumour Imatinib Concentrations in Gastrointestinal Stromal Tumours: Relevant or Redundant?
    Giraud, Eline L.
    de Jong, Loek A. W.
    van den Hombergh, Erik
    Kaal, Suzanne E. J.
    van Erp, Nielka P.
    Desar, Ingrid M. E.
    CANCERS, 2023, 15 (11)
  • [40] Resection of focally progressive gastrointestinal stromal tumours resistant to imatinib therapy
    Tse, G.
    Wong, E.
    O'Dwyer, P.
    BRITISH JOURNAL OF SURGERY, 2011, 98 : 88 - 88
12345